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ABSTRACT 
Objective: The present study aimed at designing of floating matrix tablet of clopidogrel bisulphate by design of experiments.  
Methods: The tablets were prepared by direct compression technique using hydroxypropyl methylcellulose K15 (HPMC) as a matrix polymer and 
sodium bicarbonate as a gas generating agent. In order to optimize the concentration of HPMC (X1) and sodium bicarbonate (X2), a 32 full factorial 
design was employed. The tablet formulations were evaluated for floating lag time (Y1), floating or buoyancy time (Y2), percent water uptake, and 
differential scanning calorimetry (DSC) and in vitro drug release (Y3).  
Results: The formulation variables, HPMC concentration, and sodium bicarbonate concentration exerted a significant effect on floating behavior and 
drug release characteristics of the tablet. The optimized formulation, with 15% sodium bicarbonate concentration and 30 % HPMC concentration 
resulted in 5±2.6 sec of floating lag time, 22.0±0.6 h of floating time and 42.0±0.99% of clopidogrel bisulphate release in 8 h of dissolution study. The 
drug release mechanism was identified as nonfickian. The water uptake studies revealed that with an increase in HPMC concentration, there was an 
increase in swelling index of tablet whereas higher sodium bicarbonate concentration supported the faster erosion of matrix tablets. DSC study revealed 
no interaction of drug and polymers. The lower percentage error between predicted and observed responses of the optimized formulation validated the 
design.  
Conclusion: The study demonstrated successful designing of floating clopidogrel bisulphate tablet with factorial design. 
Keywords: Clopidogrel bisulphate, Antiplatelet drug, Floating tablet, Design of experiment, Factorial design, Gastroretentive drug delivery 




Platelet aggregation has a major role in the clotting process and 
thrombosis [1]. Platelet hyper-reactivity in atherosclerosis and 
inflammatory disorders may result in serious conditions like acute 
coronary syndromes, increasing incidences of thrombosis and 
vascular occlusion [2]. The coronary events may lead to 
cardiovascular diseases (CVD), brain ischemia, peripheral arterial 
disease and other hemorrhagic disorders [3] and are the major 
causes of mortality and morbidity. Coronary artery disease (CAD) is 
a major cause of critical illness and amongst the top five causes of 
death in Indian population [4]. In India, almost 24.8% of all deaths 
are due to CAD and CVD, and 52% of deaths occur before the age of 
70. This has resulted in high social and economic burden [5].  
The importance of antiplatelet therapy in the treatment and 
prevention of atherothrombosis is well established. Each antiplatelet 
agents have a different mechanism of action and mostly interfere 
with one or more steps of thrombus formation including platelet 
release, adhesion, activation, and aggregation [6]. One of the most 
commonly used antiplatelet drugs is aspirin that exerts its action by 
inhibition of cyclooxygenase enzyme and reduction of thromboxane 
A2 levels. However, due to the lower efficacy of aspirin in reducing 
ischemic events, most of the clinical research currently is focused on 
clopidogrel therapy [7]. 
Clopidogrel is a second generation thienopyridine commonly used in 
broad spectrum therapy of acute coronary syndromes. Its 
antiplatelet activity is the result of selective inhibition of ADP 
binding to the platelet receptor preventing ADP-mediated platelet 
responses [8]. Clopidogrel is a prodrug that transforms into active 
drug after biotransformation in the liver. Various clinical trials have 
demonstrated the safety and efficacy of clopidogrel ineffective 
treatment of peripheral artery disease [9]. Although not completely 
understood, the variability in the antiplatelet effect of clopidogrel is 
attributed to its variable gastrointestinal absorption which is a 
result of low solubility [10]. The solubility of clopidogrel is mainly 
reported to be pH dependent, showing higher solubility in acidic pH 
and solubility drops when pH increases above 3.0 [11]. Taking this 
into account, a gastroretentive drug delivery system, releasing the 
maximum drug in acidic stomach pH would be desirable.  
Gastroretentive drug delivery is suitable for drugs that have a 
solubility in acidic pH, absorption window in the upper small 
intestinal region or act locally. Out of the various approaches used 
for gastro retention, the floating drug delivery system appears to be 
the most promising one [12, 13]. The floating systems that have 
been previously reported are tablets, beads, microspheres, pellets, 
etc., out of which tablets are easiest and simplest to manufacture 
[14-16]. In one of our previous study, we designed an immediate 
release pellet formulation of clopidogrel bisulphate [17]. In the 
present study, a floating matrix gastroretentive tablet of clopidogrel 
bisulphate was attempted. The formulation was designed using 32 
full factorial design in order to optimize formulation variables. The 
prepared tablets were evaluated for in vitro characteristics. 
MATERIALS AND METHODS 
Clopidogrel bisulphate was obtained as gift sample from Sava 
Healthcare, Pune, India. HPMC K15 was obtained from Colorcon, 
India. All the chemicals and solvents were of analytical grade.  
Drug-excipient compatibility study 
During the formulation of tablets, there are chances of drug 
degradation as well as unstable product formation due to drug-
excipient chemical interactions. Hence, drug and excipient 
compatibility study is required. Preformulation studies were 
conducted with various commonly used excipients at 40 °C±2 
°C/75%±5% RH and 30 °C±2 °C/65%±5% RH. The drug, along with 
different excipients, in 1:1 ratio was mixed, sealed in clear glass vials 
with LDPE stoppers, which were then charged into stability 
chambers (Remi, CHM 16, India) at the above-mentioned conditions. 
The vials were inspected periodically to observe physical changes 
and discoloration. For comparison of physical changes and 
discoloration, initial samples were used as reference sample. The 
physical observation was done after one month. At the end of one 
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month, the samples were analyzed by FTIR (Shimadzu, 8400S, 
Japan) to observe any chemical changes in the blend.  
Formulation of clopidogrel bisulphate floating tablets 
Clopidogrel bisulphate, polymers, and excipients were mixed 
thoroughly and passed though sieve 60. The tablets with different 
composition (table 1) were prepared by direct compression 
technique on a rotary punch tablet compression machine (Rimek 
mini press, MT-II, India). The powder was weighed and individually 
filled in the die cavity (10 mm diameter), and constant pressure was 
applied. The tablets were evaluated for various parameters like 
thickness, average weight, hardness, drug content, floating lag time, 
floating time, water uptake studies and in vitro drug release. 
Optimization using a factorial design 
After initial trials of floating tablets, the concentration of sodium 
bicarbonate and HPMC K15 were identified as high-risk formulation 
variables. In order to optimize the levels of these two variables, a 32 
full factorial design was applied. The design consisted of two 
independent variables with three levels resulting in 9 experimental 
runs (table 1). The first independent variable was HPMC K15 
concentration (X1) at levels 20, 30 and 40% w/w and the other 
independent variable was sodium bicarbonate concentration (X2) at 
levels 5, 10 and 15 % w/w.  
The effect of these variables on responses, floating lag time (Y1) 
and drug release after 8 h (Y2) was evaluated. The resulting data 
were fitted into design expert software (Design Expert, version 10, 
Stat-ease, USA) and analyzed statistically. The multiple linear 
regression analysis was done to study the effect of variables on the 
responses. The statistical significance of the data was established 
using analysis of variance (ANOVA).  
The surface response and contour plots were generated to study 
the interactive effects of the variables. 
 
Table 1: 32 factorial design for optimization of clopidogrel bisulphate tablets 
Ingredient (mg) F1 F2 F3 F4 F5 F6 F7 F8 F9 
Clopidogrel bisulphate 98 98 98 98 98 98 98 98 98 
HPMC K15M  (X1)* 60 (20%) 90 (30%) 120 (40%) 60 (20%) 90 (30%) 120 (20%) 40 (20%) 90 (30%) 120 (40%) 
Sodium bicarbonate (X2)* 15 (5%) 15 (5%) 15 (5%) 30 (10%) 30 (10%) 30 (10%) 45 (15%) 45 (15%) 45 (15%) 
Avicel PH 101 121 91 61 106 76 46 91 61 31 
Talc 3 3 3 3 3 3 3 3 3 
Magnesium stearate 3 3 3 3 3 3 3 3 3 
Total weight (mg) 300 300 300 300 300 300 300 300 300 
*values in the bracket indicate a concentration in percentage of the total tablet weight 
 
Evaluation of tablets 
Thickness, average weight, and hardness 
The thickness of tablets was determined using a vernier caliper. 
Hardness of tablets was determined using a Monsanto hardness 
tester. Twenty tablets of each formulation were weighed using 
electronic balance, and average tablet weight was calculated. 
Drug content 
Three tablets from each formulation were triturated in mortar and 
pestle. Powder equivalent to 75 mg of clopidogrel was weighed and 
dispersed into 20 ml of methanol and sonicated for 15 min. The 
volume was made with a hydrochloric acid buffer solution pH 2.0. 
The resultant solution was then filtered through a 0.45µ filter and 
further diluted with the same buffer solution. Drug content was 
spectrophotometrically determined at 240 nm (Shimadzu, UV 1700, 
Japan). The mean of three determinations was calculated.  
Floating lag time and total floating time 
Floating lag time and total floating time of tablets was determined 
using a method by Gharti et al. [18]. The tablets were placed in a USP 
type II dissolution test apparatus containing 900 ml of pH 2.0 
hydrochloric acid buffer solution at 37±0.5 °C and 50 rpm. The time 
required for the tablet to rise to the surface of the dissolution media 
and total time for which the tablets remained at the surface were 
noted as floating lag time and total floating time respectively. 
Swelling study 
The swelling study of clopidogrel bisulfate tablets was conducted in 
order to study polymer swelling and rate of test medium uptake by 
tablets. The preweighed tablets were placed in a USP type II 
dissolution test apparatus. The test medium used was pH 2.0 
hydrochloric acid buffer solution maintained at 37±0.5 °C and 50 
rpm. At regular intervals viz., 1, 2, 3, 4, 5, 6, 7 and 8 h, tablets were 
removed from the dissolution media, lightly blotted with tissue 
paper to remove excess dissolution fluid and weighed [19].  
The percentage water uptake was estimated for each time point 
using the following formula. 
Percent water uptake
=
(weight of swollen tablet matrix − initial weight of tablet)
initial weight of tablet
 X100 
Differential scanning calorimetry 
The DSC measurement of the drug, physical mixture and tablet 
formulation was performed on a differential Scanning calorimeter 
(Shimadzu, DSC 60, Japan) with the thermal analyzer. All accurately 
weighed samples (5 mg) were placed in sealed aluminum pans, 
before heating under nitrogen flow (10 ml/min) at a scanning rate of 
10 °C/min from 35 °C-300 °C. 
Drug release studies 
In order to check drug release profiles and dissolution kinetics, 
drug release studies of tablet formulations were conducted using 
USP apparatus II. The conditions of dissolution were as per USP 
XXIII monograph with 900 ml of hydrochloric acid buffer (pH 
2.0) solution as dissolution media. The speed of rotation was 50 
rpm, and the temperature was maintained at 37±0.5 °C. Aliquots 
of the sample were withdrawn after every 1 hour, and the study 
was continued up to 8 h. Withdrawn samples were filtered, 
diluted appropriately and analyzed on a UV spectrophotometer 
at 240.0 nm using dissolution medium as a blank. An equivalent 
volume of fresh dissolution medium was added to compensate 
for the loss due to sampling. The experiment was performed in 
triplicate and results were expressed as mean values with 
standard deviation. In order to study the mechanism of drug 
release, the data of dissolution was fitted to different kinetics 
model, viz. zero order, first order, Higuchi matrix, Korsemayar-
Peppas and Hixson-Crowell [20]. 
RESULT AND DISCUSSION 
Drug-excipient compatibility study 
Drug-excipient compatibility was assessed through FTIR analysis of 
mixtures of excipients and drug substances in the solid state. From 
the physical observations of the blends, no significant physical 
changes in colour or appearance were observed at 40 °C±2 °C/ 
75%±5% RH and 30 °C±2 °C/65%±5%RH as compared to initial. 
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FTIR spectrum of clopidogrel bisulfate shows major peaks at 
3389.0 for–N-H stretch, 2534.5 for–SH, 1751.4 cm-1 for–C=O 
stretch and 783.1 for-C-Cl stretch (fig. 1). The similar peaks at 
characteristic wave numbers were observed in the physical 
mixture of drug and excipients. This indicated the absence of any 
interaction and compatibility of drug and excipient. 
 
Fig. 1: FTIR spectra of (a) clopidogrel bisulphate (b) clopidogrel bisulphate and avicel mixture (c) clopidogrel bisulphate and HPMC K15 
mixture 
 
Optimization of tablet formulations using a factorial design 
In a sustained release floating tablet, the concentration of gas 
generating agent, sodium bicarbonate and type and concentration of 
swelling polymer are critical formulation variables. In literature, the 
use of HPMC as a swellable polymer in the formulation of sustained 
release floating tablet has been suggested [18]. Considering the low 
solubility of clopidogrel bisulphate, HPMC K15 grade with viscosity 
of 10000 to 15000 mPa. s was selected as the polymer in the present 
study. In order to systematically evaluate the effect of concentration 
of HPMC K15(X1) and sodium bicarbonate (X2) on properties of 
floating tablet, a 32 full factorial design was applied. The results of 
independent variables on key responses, floating lag time (Y1), 
floating time (Y2) and drug release in 8 h (Y3) is depicted in table 2. 
The hardness of the tablets was found in the range of 5.0 to 6.3 kg/cm2. 
The weights of tablets were within the weight variation limits as per 
USP. The lower values of friability indicate that tablets are resistant to 
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mechanical shocks. The drug content of tablet formulation was found in 
the range 91.21±1.15 to 97.12±2.64 %. The floating lag time was found 
in the range of 3±1.0 to 69±5.5 sec and total floating or buoyancy time 
was in the range of 9.0±0.0 to 22.0±0.6 h. 
 

















Drug release in 
8h (%)* 
(Y3) 
F1 0.14 5.0±2 5±2 294.6±2.5 97.12±2.64 34±1.0 16.3±0.6 67.7±1.23 
F2 0.19 5.1±1.6 4±1 294.0±2.5 96.94±2.65 41±0.5 18.3±0.0 43.9±1.63 
F3 0.20 5.5±1.6 5±1 292.3±3.2 95.57±2 54±0.5 21.3±0.6 37.0±1.26 
F4 0.33 5.0±0.6 5±0.5 293.3±2.6 94.47±1.52 4±1.1 9.0±0.0 66.0±0.45 
F5 0.33 6.1±0.6 5±0 291.6±5.5 95.08±3.05 12±0.5 20.3±0.6 38.4±3.57 
F6 0.40 6.3±0.2 4±1 292.6±1.7 93.43±2.05 69±2.0 20.0±1.7 32.4±0.57 
F7 0.36 6.3±0.4 5±1 294.0±3.5 92.22±1.15 3±5.5 13.3±0.6 67.9±1.40 
F8 0.33 6.3±0.8 5±1.5 292.3±4.0 91.21±1.15 5±2.6 22.0±0.6 42.0±0.99 
F9 0.26 6.1±1.4 5±2 295.0±2.0 91.74±1.52 7±3.0 22.0±0.6 33.4±0.89 
mean±SD *n=3, **n=10, #n=20 
 
The response data was fitted to linear regression analysis and 
equations, 1, 2 and 3 were obtained.  
Floating lag time (Y1) =+25.44+14.83 X1-19.00 X2–4.00 X1X2………….1 
Floating time (Y2) =+18.09+4.17 X1+0.23 X2+0.92 X1X2……………………. 2 
Drug release (Y3) =+47.63–16.47 X1–0.88 X2–0.95 X1X2……………………. 3 
In equation 1, the positive coefficient of X1 indicated an increase in 
floating lag time with an increase in HPMC concentration and a 
negative coefficient of X2 indicated a decrease in floating lag time with 
an increase in sodium bicarbonate concentration. The presence of 
interactive term indicated the interactive effect of both the variables 
on the response. 
For floating time, equation 2 was obtained in which the coefficients 
of X1 and X2 were positive. The increase in sodium bicarbonate 
concentration, as well as HPMC concentration, would result in an 
increase in floating time. 
Equation 3 presented the effect of X1 and X2 on response Y3 that is 
drug release after 8 h. Negative coefficient of X1 indicated a decrease 
in drug release after increase in HPMC concentration and increase in 
sodium bicarbonate concentration also decreased drug release. 
These effects can be further explained by response plots generated 
using regression data. These plots are shown in fig. 2, 3 and 4. 
Effect on floating lag time 
The response surface plot (fig. 2) demonstrated the effect of HPMC 
concentration (X1) and sodium bicarbonate concentration (X2) on 
floating lag time. A significant decrease in floating lag time was 
observed with an increase in sodium bicarbonate concentration. At 
20% HPMC (-1 level) concentration, floating lag time decreased from 
34 sec to 3 sec with increase in sodium bicarbonate concentration 
from 5% to 15%. As sodium bicarbonate is a gas generating agent, 
higher concentration of sodium bicarbonate accelerates the 
formation of carbon dioxide that gets entrapped in the gel layer of 
swollen tablet matrix altering the density of the tablet. This results 
in floating of the tablet. With the increase in HPMC concentration, 
there was an increase in floating lag time. This increase in lag time 
could be attributed to lag time in the wetting of HPMC matrix due to 
its higher concentration. 
 
 
Fig. 2: Surface response plot showing influence of HPMC and sodium bicarbonate concentration on floating lag time 
 
Effect on floating time 
Fig. 3 demonstrates the effect of HPMC concentration and 
sodium bicarbonate concentration on floating time. There is no 
significant effect of sodium bicarbonate concentration on 
floating time. With the increase in HPMC concentration, there 
was increase in floating time of tablet formulation. Higher 
concentration of polymer resulted in viscous gel matrix that 
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aided in entrapment of released carbon dioxide in tablet matrix. 
This helped in floating of the tablet for a prolonged duration. The 
surface plot indicates that at highest level of HPMC, the floating 
time is more than 22 h. 
 
 
Fig. 3: Surface response plot showing influence of HPMC and sodium bicarbonate concentration on floating time 
 
Effect on drug release 
The drug release was found to be dependant on HPMC concentration 
(fig. 4). There was no significant effect of sodium bicarbonate 
concentration on the release of the drug. Increase in polymer 
concentration from 20% to 40% of tablet weight decreased the drug 
release from 66.0±0.45 to 32.4±0.57% at the middle level of sodium 
bicarbonate (F4 to F6). This decrease in drug release could be 
attributed to increase in thickness of swollen polymer gel layer 
acting as a barrier for drug diffusion. 
  
 
Fig. 4: Surface response plot showing the influence of HPMC and sodium bicarbonate concentration on drug release in 8 h 
 
Water uptake studies 
Hydrophilic polymers have been well known to retard the drug 
release by swelling in aqueous media. In general, because the drug 
core of polymer tablets is glassy, the drug cannot diffuse unless 
swelling takes place. On swelling drug molecules dissolve in water 
and are released by diffusion. The process of swelling, erosion and 
drug release can occur simultaneously and are interconnected. An 
ability of polymers to retard the drug release rate is related to its 
viscosity. During swelling of the polymer the macromolecular 
chains absorb water, leading to an expansion of the network 
formed and formation of a quasi-equilibrium structure. This 
network structure usually is held together by physical chain 
entanglements, hydrogen bond, tie junctions produced by various 
types of forces. Upon further absorption of water, these gels may 
start disentangling, indicating a competitive phenomenon of 
swelling and dissolution.  
Fig. 5 shows the water uptake (%) by floating sustained release matrix 
tablets of clopidogrel bisulphate. It is evident that HPMC K15 
undergoes hydration as soon as it comes in contact with the medium. 
As the concentration of polymer was increased, the percent water 
uptake was more. Visual observation showed that all polymer 
matrices appeared swollen almost from the beginning and a viscous 
gel mass was produced. In the case of lower polymer concentrations 
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initial dissolution stage. But further, there was a decrease in the tablet 
weight. This could be due to the reaction of sodium bicarbonate to 
release carbon dioxide and simultaneous release of drug resulting in 
substantial erosion of tablet matrix at lower polymer concentrations. 
 
 
Fig. 5: Percent water uptake by floating clopidogrel bisulphate tablets *mean±SD, n=3 
 
Differential scanning calorimetry 
In order to observe the changes occurred in the clopidogrel 
bisulphate during tablet formulation, DSC study was conducted. 
Fig. 6 indicates DSC of clopidogrel bisulphate, its physical 
mixture with excipients and formulation of tablet. DSC graph of 
pure drug, clopidogrel bisulphate revealed an endotherm at 174 °C 
which indicates the melting point of clopidogrel bisulphate. The 
sharpness of the endotherm revealed crystalline nature of the 
drug. The physical mixture of drug and excipients demonstrated 
broad endotherm of the drug at 174 °C followed by another 
broad endotherm at 180 to 205 °C. Similar DSC graph was 
observed for formulation. This could be because of the glass 
transition temperature of HPMC K15 in the range of 170 to 190 
°C. As the melting point of the drug lies in the same range, there 
is overlapping of endotherm of clopidogrel bisulphate and HPMC 
K15 resulting in broadening of drug endotherm. There was no 
significant difference was observed in DSC curve of physical 
mixture and formulation indicating absence of any change or 
interaction between drug and excipients. 
 
 
Fig. 6: DSC of (a) clopidogrel bisulphate (b) a physical mixture of drug and excipients (c) tablet formulation F8 
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In vitro drug release profile 
Fig. 7 indicates the drug release profile for all the nine tablet 
formulations. All the nine formulations showed sustained drug release 
over 8 h of dissolution. The drug release was found in the range of 
32.4±0.57 to 67.9±1.40 % in 8 h of dissolution. These results are 
different from the study by Rao et al.[21], where the authors reported 
more than 80 % of clopidogrel bisulfate release in 8 h of dissolution. 
These results could be due to different excipients used in the 
composition of tablet and different dissolution media. As the solubility 
of clopidogrel bisulphate is highly pH dependant, change in the pH of 
dissolution of media would result in change in the dissolution profile. 
For 20% (F1, F4, and F7) and 30% (F2 and F8) cocentration of 
HPMC, a biphasic release pattern was observed. There was a burst 
release followed by sustained release of the drug. The burst release 
observed during first half hour of dissolution could be due to the 
initial lag time required for hydration of polymer and thus, the 
formation of gel layer. Hence, the surface bound drug was 
immediately released. Further swelling of polymer matrix provides a 
diffusional barrier allowing sustained release of the drug. On the 
physical evaluation of tablets during dissolution study, it was found 
that tablets swell initially and form a strong viscous gel on contact 
with the dissolution medium. 
Fig. 8 shows the effect of HPMC concentration on in vitro drug 
release. With the increase in polymer concentration, the initial burst 
release of drug as well as the overall drug release was decreased. 
The increase in polymer concentration allows quicker hydration of 
polymer and lower exposure of drug to dissolution media. The 
viscosity of the gel matrix also increases at higher polymer 
concentration. 
The data obtained from the release profile of floating sustained 
release matrix tablets of clopidogrel bisulphate was introduced to 
various mathematical models using PCP Disso software to ascertain 
the mechanism of drug release from the tablet.  
The kinetic values obtained from various mathematical models are 
shown in table 3. 
  
 
Fig. 7: In vitro drug release profile of clopidogrel bisulphate floating tablet formulations, *mean±SD, n=3 
 
 
Fig. 8: Effect of HPMC cocentration on in vitro drug release. (20%, 30%, 40%), *mean±SD, n=3 
 
Table 3: Kinetic values of drug release data for clopidogrel bisulphate tablets 
Formulation 
code 
Zero-order First order Hixon-crowell Higuchi Korsmeyer peppas 
R2 R2 R2 R2 K R2 N 
F1 0.5193 0.8267 0.7508 0.9423 25.48 0.9951 0.28 
F2 0.6879 0.8185 0.7809 0.9675 15.37 0.9785 0.31 
F3 0.9634 0.9803 0.9760 0.9792 11.02 0.9915 0.58 
F4 0.7957 0.9326 0.8971 0.9927 24.6 0.9977 0.44 
F5 0.9379 0.8988 0.9133 0.8428 9.93 0.9532 0.97 
F6 0.9779 0.9868 0.9847 0.9660 9.7 0.9808 0.61 
F7 0.4234 0.7802 0.6932 0.9264 25.3 0.9944 0.26 
F8 0.7440 0.8509 0.8203 0.9675 14.45 0.9504 0.31 
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In general, fickian diffusion was used to describe the release of the 
drug from the matrix tablets. However, in the case of swelling 
polymers, the release kinetics of the drug did not follow fickian 
diffusion because the polymer swells and changes volume. In order 
to describe drug release from swelling polymers, Korsmeyer and 
Peppas equation called the “power law” was applied. This equation 
correlates two mechanisms of drug transport that seem 
independent, fickian diffusion and a case-II transport, thereby 
describing the release of a drug from a swelling polymer. When n is 
0.45, drug release is diffusion-controlled; when n is 0.89, drug 
release is swelling-controlled. When n is between 0.45 and 0.89, 
release can be defined as a combination of both phenomena. Table 3 
shows the values of n and all of the correlation coefficients for each 
formulation. In almost all the formulations, higher R2 values 
suggested that Korsemayer Pappas kinetic model was satisfied. The 
formulations with lower HPMC concentrations (20% and 30%), 
value of n was approximately lower than 0.5. This suggested that the 
drug release was erratic and in burst changing the shape of the 
matrix tablet. When the polymer concentration was increased to 
40%, n value of Korsemayer Pappas was above 0.55 to 0.61 
indicating drug release following nonfickian diffusion that is drug 
release was both diffusion and swelling controlled. 
Search for the optimized formulation of floating matrix tablet 
The criteria for the selection of optimized formulation was primarily 
based upon the lower values of floating lag time (less than 1 min), 
higher floating time (equal to or more than 22 h) and sustained drug 
release. Based on these criteria, a formulation with 30% HPMC 
concentration and 15% sodium bicarbonate concentration, was 
selected as optimized formulation. 
Fig. 9 indicates an overlay plot and table 4 indicates a comparison of 
predicted and experimental results. Upon comparison of the 
observed responses with that of the predicted responses, the 
percentage error varied between 1.1 to 5.0 %. Thus, the low 
magnitudes of error indicated validation of the experimental design. 
 
 
Fig. 9: Overlay plot indicating design space and optimized formulation 
 
Table 4: Comparison of experimental results with predicted responses of formulation 
Batch 
code 












Floating lag time 5.7 sec 5 sec 5.0% 
Floating time 18 h 22 h 2.3% 
Drug release in 8 h 47.9% 42.0% 1.1% 
 
CONCLUSION 
The floating matrix tablet of clopidogrel bisulphate was successfully 
designed. The concentration of HPMC and sodium bicarbonate exerted 
a significant effect on characteristics of the tablet. The optimized 
formulation resulted in greater floating time and sustained drug 
release by nonfickian mechanism. Conclusively, a sustained floating 
matrix tablet of clopidogrel bisulphate was successfully designed by 
factorial design. 
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X1 = a: HPMC concentration
X2 = B: Sodium bicarbonate concentration
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